A benchmarked MCNP model of the in vivo detection of gadolinium by prompt gamma neutron activation analysis

Gadolinium (Gd)-based contrast agents are a valuable diagnostic aid for magnetic resonance imaging (MRI). The amount of free Gd deposited in tissues following contrast enhanced MRI is of toxicological concern. The McMaster University in vivo prompt gamma neutron activation analysis facility has been adapted for the detection of Gd in the kidney, liver, and the leg muscle. A simple model of the HPGe detector used for detection of the prompt γ-rays following Gd neutron capture has been created using Monte Carlo simulation. A separate simulation describing the neutron collimation and shielding apparatus has been modified to determine the neutron capture rate in the Gd phantoms. The MCNP simulation results have been confirmed by experimental measurement. The deviations between MCNP and the experiment were between 1% and 18%, with an average deviation of 3.8±6.7%. The validated MCNP model is to be used to improve the Gd in vivo measurement sensitivity by determining the best neutron moderator/reflector arrangement.